Dynaderm SPRL
The score of Dynaderm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -39 % Total assets -25 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dynaderm's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 22 Apr 2026
- Year ended 30 Sep 2024filed on 30 Apr 2025
- Year ended 30 Sep 2023filed on 30 Apr 2024
- Year ended 30 Sep 2022filed on 27 Jul 2023
- Year ended 30 Sep 2021filed on 22 Mar 2022
Dynaderm's financial analysis
- Solvency46.3%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dynaderm
Dynaderm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0479.019.949
- VAT number
- BE0479019949
- Peppol
- Registered · 0208:0479019949 · as of 09 Nov 2026
- Legal form
- SPRL
- Incorporated
- 12 Dec 2002
- Registered office
- 1300 Wavre
- Latest accounts
- 2025 · filed on 22 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Dynaderm (SPRL) has been based in Wavre since 2002, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 11,782 € and equity of 22,050 €; its revenue is not published. Its solvency stands at 46.3%, above the median of its sector (41.5%).
Companies similar to Dynaderm
Companies in the same business, of comparable size and area, outside its group.
- Quality Pharmaceutical Service Retail sale of pharmaceutical products La Bruyère · balance sheet 110,124 €
- Ahonzo Corporate Retail sale of pharmaceutical products Etterbeek · balance sheet 49,700 €
- Codema Pharma Retail sale of pharmaceutical products Brussels · balance sheet 375,959 €
- Sulayman Retail sale of pharmaceutical products Enghien · balance sheet 59,800 €
- T.R.F. pharma Retail sale of pharmaceutical products Fléron · balance sheet 70,151 €
- Pharmacie VAN Achter Retail sale of pharmaceutical products Ixelles · balance sheet 193,448 €
- Smartvalue Distribution Wholesale of pharmaceutical and medical goods Liège · balance sheet 56,516 €
- Alchemiste Retail sale of pharmaceutical products Aalter · balance sheet 73,555 €
Frequently asked questions about Dynaderm
What is the revenue of Dynaderm?
Dynaderm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dynaderm?
In Belgium, the VAT number is the company number prefixed with BE: BE0479019949 for Dynaderm, if the company is VAT-registered. Its company number (CBE) is 0479.019.949.
Where is the registered office of Dynaderm?
According to the CBE register, the registered office of Dynaderm is in 1300 Wavre.
What is the equity of Dynaderm?
At the close of the 2025 financial year, the equity of Dynaderm amounts to 22,050 €, a solvency of 46.3% of total assets.
Who manages Dynaderm?
The register lists 1 active mandates at Dynaderm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dynaderm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →